Michael McClelland works in the field of Urology. He studied medicine at University of Kansas School of Medicine. He received 2 awards: "Meaningful Use Stage 1 Certification" and "Super Doctor". Michael McClelland has written publications. He has 15 publications published with PubMed. The lastest publication is: 'High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with 240-Fold Higher Drug Concentration in Urine than Serum.' Michael McClelland is registered with Medicare and accepts Medicare payments.
![]() |
Dr. Herb Singh, MD
![]() |
![]() |
Dr. Sandeep G. Mistry, MD
![]() |
![]() |
Dr. Michael D. Trotter, MD
![]() |
![]() |
Dr. George M. Seremetis, MD
![]() |
![]() |
Dr. Melody A. Denson, MD
![]() |
![]() |
Dr. Elizabeth Rutledge, MD
![]() |
![]() |
Dr. Brett W. Baker, MD |
![]() |
Dr. Loren R. Jones, MD
![]() |
![]() |
Dr. Joseph E. West III, MD |
![]() |
Dr. Michael K. Floyd, MD |
![]() |
Dr. Matthew D. Pearson, MD |
![]() |
Dr. John J. Horan, MD
![]() |
![]() |
Dr. Subir Chhikara, MD
![]() |
![]() |
Dr. Christopher Yang, MD
![]() |
![]() |
Dr. Parviz K. Kavoussi, MD
![]() |